2018

As we posted last week, the Nevada draft regulations are up and starting to become a hot topic. The same day as our last post,…

As life science compliance professionals know, it is important to monitor what the HHS OIG focuses on. This article reviews the…

On January 9, 2018, the Senate Finance Committee held a nomination hearing for Alex Azar, President Trump’s pick to lead the…

Maine has posted a revised version of their gifts to physicians law which bans cash payments from pharmaceutical manufacturers,…

The topic of ‘company culture’ is certainly not new, but it continually emerges as a hot topic within regulatory circles. An…

Many would say that the media is no friend to the pharmaceutical industry. However, CNN has recently started to (seemingly) build…

We have written many times on the Nevada law passed in Summer 2017 that requires patient advocacy organizations to report all…

United States Senators Susan Collins and Claire McCaskill, the Chairwoman and Ranking Member of the Senate Aging Committee,…

A report recently released by the Department of Health and Human Services (HHS) Office of Inspector General (OIG) found that…

In an unusual administrative move – without passing any new laws – on December 22, 2017, the Attorney General of New Jersey…